Click here to read this on StonyFinLab.org
|
|
|
|
|
|
|
The first-ever Japan Private Capital Breakdown unpacks the state of PE and VC dealmaking in the world's third-largest economy, where private markets may be entering a period of high growth.
|
|
|
|
|
The article looks at the most active PE investors in the space, which includes biotech and medical device companies as well as providers of related tools and services.
|
|
|
|
|
|
Members of iStrat Team share their research on the composition of the opportunity set, the growing divergence in the behavior of EM ex-China equities and Chinese equities, and the long-term market outlook.
|
|
|
|
|
China’s multi-decade period of high growth has come to an end, but the opportunities for investors have not, argue Evan Brown and Sylvia Liang.
|
|
|
|
|
|
Join Christoph Schon in this webinar to hear his thoughts on multi-asset risk and more over the coming year. The webinar is on December 14, 2023
|
|
|
|
|
This webinar will go through the key drivers of risk and return in portfolios for the past quarter as well as their impact on investor sentiment. The webinar is on December 19, 2023
|
|
|
|
|
|
1. 14 Dec 2023: Market Perspectives – Outlook 2024 – A world in transition (Online): [Click here] 2. 10 Jan 2024: Biopharma VC in flux: Unpacking the data and 2024 outlook (Online): [Click here] 3. 12 Jan 2024: J.P. Morgan Healthcare 2024 recap: Private markets highlights and the year ahead (Online): [Click here]
|
|
|
|
|
|
Thanks to our members and volunteers for contributions to this newsletter. To share information or research with the community, submit it through "Share" below. We will include it if the content is deemed appropriate. Support our efforts to make free and useful financial education content by donating to @stonyfinlab via Venmo!
|
|
|
|
|
|
Stony Finance Lab is a community-based finance network that aims to promote personal financial responsibility and helps the community to achieve financial confidence and financial independence through life-long learning. The emails are to distribute news and information on finance research, events, jobs related to personal finance, investments of financial and digital assets, academic finance, and entrepreneurship. All emails are for information sharing only and shall not be deemed as financial advice. The Lab is not liable for the consequence of using any information contained in the emails.
|
To subscribe to our mailing list using an alternative email address:
|
|
|
|
|
To unsubscribe from our mailing list:
|
|
|
|
|
|